# EDGAR Filing Document

**Accession Number:** 0000010456
**File Stem:** 0001628280-25-054015
**Filing Date:** 2025-11
**Character Count:** 24071
**Document Hash:** 4fdbe567cc88601febe434698e4cd285
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001628280-25-054015.hdr.sgml**: 20251125

**ACCESSION NUMBER**: 0001628280-25-054015

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 14

**CONFORMED PERIOD OF REPORT**: 20251125

**ITEM INFORMATION**: Entry into a Material Definitive Agreement

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20251125

**DATE AS OF CHANGE**: 20251125

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** BAXTER INTERNATIONAL INC
- **CENTRAL INDEX KEY:** 0000010456
- **STANDARD INDUSTRIAL CLASSIFICATION:** SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 360781620
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-04448
- **FILM NUMBER:** 251522177

**BUSINESS ADDRESS:**
- **STREET 1:** ONE BAXTER PARKWAY
- **CITY:** DEERFIELD
- **STATE:** IL
- **ZIP:** 60015
- **BUSINESS PHONE:** 2249482000

**MAIL ADDRESS:**
- **STREET 1:** ONE BAXTER PARKWAY
- **CITY:** DEERFIELD
- **STATE:** IL
- **ZIP:** 60015

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** BAXTER TRAVENOL LABORATORIES INC
- **DATE OF NAME CHANGE:** 19880522

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** BAXTER LABORATORIES INC
- **DATE OF NAME CHANGE:** 19760608

?xml version='1.0' encoding='ASCII'? bax-20251125

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM 8-K**

**CURRENT REPORT**

**PURSUANT TO SECTION 13 OR 15(D)**

**OF THE SECURITIES EXCHANGE ACT OF 1934**

**Date of Report (Date of earliest event reported): November 25, 2025**

**Baxter International Inc.** 

**(Exact name of registrant as specified in its charter)**

---

| |
|:---|
| **Delaware** |
| **(State or other jurisdiction**<br>**of incorporation)** |

---

---

| | |
|:---|:---|
| **1-4448** | **36-0781620** |
| **(Commission**<br>**File Number)** | **(I.R.S. Employer**<br>**Identification No.)** |

---

---

| | | | |
|:---|:---|:---|:---|
| **One Baxter Parkway,** | **Deerfield,** | **Illinois** | **60015** |
| **(Address of principal executive offices)** | **(Address of principal executive offices)** | **(Address of principal executive offices)** | **(Zip Code)** |

---

**(224) 948-2000**

**(Registrant's telephone number, including area code)**

**(Former name or former address, if changed since last report)**

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d 2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| **Title of each class** | **Trading**<br>**Symbol(s)** | **Name of each exchange**<br>**on which registered** |
| **Common Stock, $1.00 par value** | **BAX (NYSE)** | **New York Stock Exchange** |
| **1.3% Global Notes due 2029** | **BAX 29** | **New York Stock Exchange** |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter):

☐ Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act: ☐

------

**Item 1.01 Entry into a Material Definitive Agreement.**

On November 25, 2025, Baxter International Inc. ("<u>Baxter</u>") entered into an amendment ("<u>Amendment No. 1</u>") to the amended and restated five-year credit agreement dated June 11, 2025, among Baxter, as Borrower Representative, Baxter Healthcare SA and Baxter World Trade SRL, as Borrowers, various lenders and JPMorgan Chase Bank, N.A., as Administrative Agent (as amended by Amendment No. 1, the "<u>Amended Credit Agreement</u>"). The purpose of Amendment No. 1 is to amend the net leverage ratio covenant to increase the maximum net leverage ratio for the four fiscal quarters ending December 31, 2025, March 30, 2026, June 30, 2026, and September 30, 2026.

The description above is a summary of Amendment No. 1 and is qualified in its entirety by the complete text of Amendment No. 1, a copy of which is attached to this report as Exhibit 10.1 and incorporated herein by reference. Capitalized terms used but not otherwise defined herein shall have the meaning as ascribed to them in the Amended Credit Agreement.

**Item 9.01 Financial Statements and Exhibits.**

(d) Exhibits.

10.1 <u>[Amendment No. 1, dated as of November 25, 2025, to the Amended and Restated Five-Year Credit Agreement, dated as of June 11, 2025, among Baxter International Inc. as Borrower Representative, Baxter Healthcare SA, Baxter World Trade SRL, JPMorgan Chase Bank, National Association, as Administrative Agent, and certain other financial institutions named therein.](exhibit101-8xk112525closin.htm)</u>

(104) Cover Page Interactive Data File (embedded within the Inline XBRL document)

------

**SIGNATURES** 

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | | |
|:---|:---|:---|
| | Baxter International Inc. | Baxter International Inc. |
| Date: November 25, 2025 | By: | /s/ Ellen K. Bradford |
|  | Name: | Ellen K. Bradford |
|  | Title: | Senior Vice President and Corporate Secretary |

---

## Exhibit 10.1

**Exhibit 10.1**

**AMENDMENT NO. 1**

AMENDMENT NO. 1, dated as of November 25, 2025 (this "<u>Amendment</u>"), among Baxter International Inc., a Delaware corporation (the "<u>Borrower Representative</u>"), Baxter Healthcare SA (the "<u>Swiss Borrower</u>"), Baxter World Trade SRL (the "<u>Belgian Borrower</u>" and, together with Borrower Representative and Swiss Borrower, the "<u>Borrowers</u>" and each, a "<u>Borrower</u>"), the Banks party hereto and JPMorgan Chase Bank, N.A., as Administrative Agent (in such capacity, the "<u>Administrative Agent</u>"). All capitalized undefined terms used in this Amendment shall have the meanings assigned thereto in the Credit Agreement (as defined below).

<u>W</u> <u>I</u> <u>T</u> <u>N</u> <u>E</u> <u>S</u> <u>S</u> <u>E</u> <u>T</u> <u>H</u>

WHEREAS, the Borrower Representative, the Swiss Borrower, the Belgian Borrower, the financial institutions party thereto (the "<u>Banks</u>") and the Administrative Agent are party to that certain Amended and Restated Five-Year Credit Agreement, dated as of June 11, 2025 (as amended, restated, supplemented or otherwise modified from time to time prior to the date hereof, the "<u>Credit Agreement</u>"; and as further amended by this Amendment, the "<u>Amended Credit Agreement</u>").

WHEREAS, pursuant to the Credit Agreement, the Banks have agreed to make, and have made, certain loans to the Borrowers;

WHEREAS, the Borrowers wish to effect certain amendments to the Credit Agreement in accordance with Section 11.01(a) of the Credit Agreement;

WHEREAS, the Banks party hereto constituting Majority Banks under the Credit Agreement, the Borrowers and the Administrative Agent are willing to agree to the terms of this Amendment and the amendments to the Credit Agreement effected hereby; and

NOW, THEREFORE, in consideration of the premises and the mutual covenants herein set forth, the parties hereto agree as follows:

ARTICLE 1.

AMENDMENTS TO THE CREDIT AGREEMENT

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) Section 8.02(c) of the Credit Agreement is hereby amended and restated in its entirety as follows:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) Net Leverage Ratio. As of the last day of any fiscal quarter (commencing with the fiscal quarter ending December 31, 2025), permit the Net Leverage Ratio on a pro forma basis for the applicable Test Period to be greater than the Net Leverage Ratio set forth in the table below:

<u>Quarter Ending or Ended</u> <u>Ratio</u>

------

---

| | |
|:---|:---|
| December 31, 2025 | 4.25 to 1.00 |
| March 30, 2026 | 4.25 to 1.00 |
| June 30, 2026 | 4.25 to 1.00 |
| September 30, 2026 | 4.00 to 1.00 |
| December 31, 2026 and thereafter | 3.75 to 1.00 |

---

<u>provided</u>, <u>however</u>, such Net Leverage Ratio shall be increased to 4.50 to 1.00 for each of the four fiscal quarters ending immediately following the consummation of any Material Acquisition.

ARTICLE 2.

REPRESENTATIONS AND WARRANTIES

Each Borrower represents and warrants to the Banks party hereto that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)The execution, delivery and performance by such Borrower of this Amendment are within such Borrower's corporate powers, have been duly authorized by all necessary corporate action, and do not contravene (i) such Borrower's charter or by-laws or (ii) any law or any contractual restriction binding on or affecting such Borrower, except in the case of this clause (ii) where the failure to do so, individually or in the aggregate, would not reasonably be expected to have a material adverse effect on the financial condition or operations of the Borrower Representative and its Consolidated Subsidiaries (taken as a whole).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)The representations and warranties set forth in Article VII of the Amended Credit Agreement are true and correct in all material respects (without duplication of any materiality qualifier contained therein) immediately prior to and as of the Amendment No. 1 Effective Date (as defined below) as if made on and as of such date (or, if any such representation or warranty is expressly stated to have been made as of a specific date, as of such specific date).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)At the time of and immediately after giving effect to this Amendment, no Event of Default or Unmatured Event of Default has occurred and is continuing.

ARTICLE 3.

CONDITIONS PRECEDENT

This Amendment shall become effective subject to the satisfaction of the following conditions (which occurred on the date hereof (such date, the "<u>Amendment No. 1 Effective Date</u>")):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)<u>Executed Counterparts</u>. The Administrative Agent shall have received executed counterparts of this Amendment from each Borrower and the Banks constituting the Majority Banks under the Credit Agreement.

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)<u>Officer's Certificate</u>. The Administrative Agent shall have received a certificate dated the Amendment No. 1 Effective Date and signed by a Responsible Officer of the Borrower Representative, certifying on behalf of the Borrower Representative the accuracy of the representations and warranties set forth in Article 2 hereof.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)<u>Fees and Expenses</u>. The Borrower Representative shall have paid all fees due and payable pursuant to that certain Fee Letter, dated as of November 14, 2025, between the Borrower Representative and the Administrative Agent. All other costs, fees and expenses payable to the Administrative Agent (including, without limitation, legal fees and expenses) shall have been paid on or prior to the Amendment No. 1 Effective Date, to the extent invoiced at least two Business Days prior to the Amendment No. 1 Effective Date.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)<u>USA PATRIOT Act, Beneficial Ownership</u>. The Administrative Agent and each requesting Bank shall have received, at least 3 Business Days prior to the Amendment No. 1 Effective Date, all documentation and other information reasonably requested in writing by the Administrative Agent or such Bank, at least 5 Business Days prior to the Amendment No. 1 Effective Date, about the Borrowers that the Administrative Agent or such Bank reasonably determines is required by regulatory authorities under applicable "know your customer" and anti-money laundering rules and regulations, including the USA PATRIOT Act and 31 C.F.R. § 1010.230.

ARTICLE 4.

GENERAL

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)<u>Limited Effect</u>. Except as expressly provided herein, the Credit Agreement and the other Loan Documents shall remain unmodified and in full force and effect. This Amendment shall not be deemed (a) to be a waiver of, or consent to, or a modification or amendment of, any other term or condition of the Credit Agreement or any other Loan Document or a waiver of any Event of Default, (b) to prejudice any right or rights which the Administrative Agent or the Banks may now have or may have in the future under or in connection with the Amended Credit Agreement or the other Loan Documents or any of the instruments or agreements referred to therein, as the same may be amended, restated, supplemented or modified from time to time, or (c) to be a commitment or any other undertaking or expression of any willingness to engage in any further discussion with the Borrower Representative or any other Person with respect to any waiver, amendment, modification or any other change to the Credit Agreement or the Loan Documents or any rights or remedies arising in favor of Banks or Administrative Agent, or any of them, under or with respect to any such documents.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)<u>Construction</u>. On and after the Amendment No. 1 Effective Date, each reference in the Credit Agreement to "this Agreement," "hereunder," "hereof," "herein" or words of like import, and each reference to the Credit Agreement in any other Loan Document, shall be deemed a reference to the Amended Credit Agreement. This Amendment shall constitute a Loan Document for all purposes of the Credit Agreement and the other Loan Documents.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)<u>Acknowledgement and Reaffirmation</u>. By its execution hereof, each Borrower hereby expressly agrees, with respect to each Loan Document to which it is a party that (a) all of its obligations, liabilities and indebtedness under such Loan Document shall remain in

------

full force and effect on a continuous basis regardless of the effectiveness of this Amendment and (b) nothing contained in this Amendment shall be construed as a substitution or novation of its obligations, liabilities and indebtedness under such Loan Document.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)<u>Execution in Counterparts; Loan Document</u>. This Amendment may be executed by one or more of the parties to this Amendment on any number of separate counterparts, and all of said counterparts taken together shall be deemed to constitute one and the same instrument. The words "execution," "signed," "signature," "delivery," and words of like import in or relating to this Amendment and/or any document to be signed in connection with this Amendment and the transactions contemplated hereby, as the case may be, shall be deemed to include Electronic Signatures, electronic deliveries or the keeping of records in electronic form, each of which shall be of the same legal effect, validity or enforceability as a manually executed signature, physical delivery thereof or the use of a paper-based recordkeeping system, as the case may be.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)<u>Governing Law</u>. **THIS AMENDMENT SHALL BE CONSTRUED IN ACCORDANCE WITH AND GOVERNED BY THE LAWS OF THE STATE OF NEW YORK**.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f)<u>Successors and Assigns</u>. This Amendment shall be binding on and inure to the benefit of the parties and their respective heirs, beneficiaries, successors and permitted assigns.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g)<u>Severability</u>. Any provision of this Amendment held to be invalid, illegal or unenforceable in any jurisdiction shall, as to such jurisdiction, be ineffective to the extent of such invalidity, illegality or unenforceability without affecting the validity, legality and enforceability of the remaining provisions hereof; and the invalidity of a particular provision in a particular jurisdiction shall not invalidate such provision in any other jurisdiction.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(h)<u>Incorporation by Reference</u>. The provisions of Sections 11.04, 11.09 and 11.10 of the Credit Agreement are hereby incorporated by reference, *mutatis mutandis*.

[Signature Pages Follow]

------

IN WITNESS WHEREOF, the parties hereto have caused this Amendment to be duly executed and delivered by their proper and duly authorized officers as of the day and year first above written.

---

| | |
|:---|:---|
| BAXTER INTERNATIONAL INC. | BAXTER INTERNATIONAL INC. |
| By: | /s/ Karen Leets |
| Name: | Karen Leets |
| Title: | Senior Vice President and Treasurer |
| Address for Notice Purposes: | Address for Notice Purposes: |
| One Baxter Parkway | One Baxter Parkway |
| Deerfield, Illinois 60015 | Deerfield, Illinois 60015 |
| Attention: Treasurer and Assistant Treasurer | Attention: Treasurer and Assistant Treasurer |

---

---

| | |
|:---|:---|
| BAXTER HEALTHCARE SA | BAXTER HEALTHCARE SA |
| By: | /s/ Karen Leets |
| Name: | Karen Leets |
| Title: | Authorized Signatory |
| Address for Notice Purposes: | Address for Notice Purposes: |
| One Baxter Parkway | One Baxter Parkway |
| Deerfield, Illinois 60015 | Deerfield, Illinois 60015 |
| Attention: Treasurer and Assistant Treasurer | Attention: Treasurer and Assistant Treasurer |

---

---

| | |
|:---|:---|
| BAXTER WORLD TRADE SRL | BAXTER WORLD TRADE SRL |
| By: | /s/ Karen Leets |
| Name: | Karen Leets |
| Title: | Authorized Signatory |
| Address for Notice Purposes: | Address for Notice Purposes: |
| One Baxter Parkway | One Baxter Parkway |
| Deerfield, Illinois 60015 | Deerfield, Illinois 60015 |
| Attention: Treasurer and Assistant Treasurer | Attention: Treasurer and Assistant Treasurer |

---

[Signature Page to Amendment No. 1]

------

---

| | |
|:---|:---|
| JPMORGAN CHASE BANK, N.A., as | JPMORGAN CHASE BANK, N.A., as |
| Administrative Agent | Administrative Agent |
| By: | /s/ Gregory T. Martin |
|  | Name: Gregory T. Martin |
|  | Title: Executive Director |

---

[Signature Page to Amendment No. 1]

------

---

| | |
|:---|:---|
| JPMORGAN CHASE BANK, N.A., as | JPMORGAN CHASE BANK, N.A., as |
| a Bank | a Bank |
| By: | /s/ Gregory T. Martin |
|  | Name: Gregory T. Martin |
|  | Title: Executive Director |

---

[Signature Page to Amendment No. 1]

------

---

| | |
|:---|:---|
| BANK OF AMERICA, N.A., as | BANK OF AMERICA, N.A., as |
| a Bank | a Bank |
| By: | /s/ Darren Merten |
|  | Name: Darren Merten |
|  | Title: Director |

---

[Signature Page to Amendment No. 1]

------

---

| | |
|:---|:---|
| CITIBANK, N.A., as | CITIBANK, N.A., as |
| a Bank | a Bank |
| By: | /s/ Eugene Yermash |
|  | Name: Eugene Yermash |
|  | Title: Vice President |

---

[Signature Page to Amendment No. 1]

------

---

| | |
|:---|:---|
| DEUTSCHE BANK AG NEW YORK BRANCH, | DEUTSCHE BANK AG NEW YORK BRANCH, |
| as a Bank | as a Bank |
| By: | /s/ Ming K. Chu |
|  | Name: Ming K. Chu |
|  | Title: Director |
| By: | /s/ Marko Lukin |
|  | Name: Marko Lukin |
|  | Title: Vice President |

---

[Signature Page to Amendment No. 1]

------

---

| | |
|:---|:---|
| Goldman Sachs Bank USA, as | Goldman Sachs Bank USA, as |
| a Bank | a Bank |
| By: | /s/ Priyankush Goswami |
|  | Name: Priyankush Goswami |
|  | Title: Authorized Signatory |

---

[Signature Page to Amendment No. 1]

------

---

| | |
|:---|:---|
| HSBC BANK USA, NATIONAL ASSOCIATION, | HSBC BANK USA, NATIONAL ASSOCIATION, |
| as a Lender | as a Lender |
| By: | /s/ Dennis Tybor |
|  | Name: Dennis Tybor |
|  | Title: Senior Vice President |

---

[Signature Page to Amendment No. 1]

------

---

| | |
|:---|:---|
| MIZUHO BANK, LTD., as | MIZUHO BANK, LTD., as |
| a Bank | a Bank |
| By: | /s/ Tracy Rahn |
|  | Name: Tracy Rahn |
|  | Title: Managing Director |

---

[Signature Page to Amendment No. 1]

------

---

| | |
|:---|:---|
| MORGAN STANLEY BANK N.A., as | MORGAN STANLEY BANK N.A., as |
| a Bank | a Bank |
| By: | /s/ Tayo Lapite |
|  | Name: Tayo Lapite |
|  | Title: Authorized Signatory |

---

[Signature Page to Amendment No. 1]

------

---

| | |
|:---|:---|
| SOCIETE GENERALE, as a Bank | SOCIETE GENERALE, as a Bank |
| By: | /s/ Shelley Yu |
|  | Name: Shelley Yu |
|  | Title: Director |

---

[Signature Page to Amendment No. 1]

------

---

| | |
|:---|:---|
| THE BANK OF NOVA SCOTIA, as | THE BANK OF NOVA SCOTIA, as |
| a Bank | a Bank |
| By: | /s/ Iain Stewart |
|  | Name: Iain Stewart |
|  | Title: Managing Director |

---

[Signature Page to Amendment No. 1]

------

---

| | |
|:---|:---|
| THE TORONTO-DOMINION BANK, NEW | THE TORONTO-DOMINION BANK, NEW |
| YORK BRANCH, as | YORK BRANCH, as |
| a Bank | a Bank |
| By: | /s/ Mike Tkach |
|  | Name: Mike Tkach |
|  | Title: Authorized Signatory |

---

[Signature Page to Amendment No. 1]

------

---

| | |
|:---|:---|
| U.S. Bank National Association, as | U.S. Bank National Association, as |
| a Bank | a Bank |
| By: | /s/ Heidi Barta |
|  | Name: Heidi Barta |
|  | Title: Vice President |

---

[Signature Page to Amendment No. 1]

------

---

| | |
|:---|:---|
| WELLS FARGO BANK, NATIONAL | WELLS FARGO BANK, NATIONAL |
| ASSOCIATION, as | ASSOCIATION, as |
| a Bank | a Bank |
| By: | /s/ Andrea S Chen |
|  | Name: Andrea S Chen |
|  | Title: Managing Director |

---

[Signature Page to Amendment No. 1]

------

---

| | |
|:---|:---|
| MUFG Bank, Ltd., as | MUFG Bank, Ltd., as |
| a Bank | a Bank |
| By: | /s/ Andrew Moore |
|  | Name: Andrew Moore |
|  | Title: Authorized Signatory |

---

[Signature Page to Amendment No. 1]